JP2007015941A - 米を除く穀類及び豆類を原料とする寿命延長剤 - Google Patents
米を除く穀類及び豆類を原料とする寿命延長剤 Download PDFInfo
- Publication number
- JP2007015941A JP2007015941A JP2005196003A JP2005196003A JP2007015941A JP 2007015941 A JP2007015941 A JP 2007015941A JP 2005196003 A JP2005196003 A JP 2005196003A JP 2005196003 A JP2005196003 A JP 2005196003A JP 2007015941 A JP2007015941 A JP 2007015941A
- Authority
- JP
- Japan
- Prior art keywords
- raw material
- product
- beans
- life
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002994 raw material Substances 0.000 title claims abstract description 30
- 235000010627 Phaseolus vulgaris Nutrition 0.000 title claims abstract description 21
- 244000046052 Phaseolus vulgaris Species 0.000 title claims abstract description 21
- 235000013339 cereals Nutrition 0.000 title claims abstract description 17
- 240000007594 Oryza sativa Species 0.000 title claims abstract description 16
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 16
- 235000009566 rice Nutrition 0.000 title claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000003960 organic solvent Substances 0.000 claims description 16
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 235000005822 corn Nutrition 0.000 claims description 10
- 235000021307 Triticum Nutrition 0.000 claims description 9
- 244000068988 Glycine max Species 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 8
- 240000005979 Hordeum vulgare Species 0.000 claims description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 8
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 239000000047 product Substances 0.000 description 37
- 108090000790 Enzymes Proteins 0.000 description 33
- 102000004190 Enzymes Human genes 0.000 description 33
- 229940088598 enzyme Drugs 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 19
- 230000002265 prevention Effects 0.000 description 17
- 238000011282 treatment Methods 0.000 description 16
- 238000000605 extraction Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 230000006872 improvement Effects 0.000 description 12
- 210000000056 organ Anatomy 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000003625 amylolytic effect Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 241000209140 Triticum Species 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 230000006866 deterioration Effects 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- 240000008620 Fagopyrum esculentum Species 0.000 description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 210000000963 osteoblast Anatomy 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- -1 facial cleansers Substances 0.000 description 2
- 210000001752 female genitalia Anatomy 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000000777 hematopoietic system Anatomy 0.000 description 2
- 206010021198 ichthyosis Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 210000000088 lip Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000005210 lymphoid organ Anatomy 0.000 description 2
- 210000003563 lymphoid tissue Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000000260 male genitalia Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 210000002741 palatine tonsil Anatomy 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 210000004560 pineal gland Anatomy 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 206010014190 Eczema asteatotic Diseases 0.000 description 1
- 206010063045 Effusion Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 240000005926 Hamelia patens Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
【解決手段】 米を除く穀類又は豆類を必須的に含む原料の処理物を有効成分として含有することを特徴とする寿命延長剤。
【選択図】 図1
Description
小麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、しぼり機でしぼり、本例品25Lと残渣13kgを得た。
大麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、しぼり機でしぼり、本例品25Lと残渣13kgを得た。
とうもろこし10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、しぼり機でしぼり、本例品12Lと残渣26kgを得た。
大豆10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、しぼり機でしぼり、本例品6Lと残渣30kgを得た。
小麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液26Lを得た。これを85℃で30分加熱して本例品を得た。
大麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液26Lを得た。これを85℃で30分加熱して本例品を得た。
とうもろこし10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液15Lを得た。これを85℃で30分加熱して本例品を得た。
大豆10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液8Lを得た。これを85℃で30分加熱して本例品を得た。
小麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後冷却し酵母を加え、15日間発酵を行った。その後濾過器を用いて固液分離を行い、ろ液26Lを得た。これを85℃で30分加熱して本例品を得た。
大麦10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく攪拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後冷却し酵母を加え、15日間発酵を行った。その後濾過器を用いて固液分離を行い、ろ液26Lを得た。これを85℃で30分加熱して本例品を得た。
とうもろこし10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後冷却し酵母を加え、15日間発酵を行った。その後濾過器を用いて固液分離を行い、ろ液15Lを得た。これを85℃で30分加熱して本例品を得た。
大豆10kgをよく粉砕し、これに60℃の温水30Lと液化酵素50gを加え、よく撹拌した。その後、徐々に温度を上げてゆき、5分間煮沸抽出した後、30℃まで冷却した。その後、澱粉分解酵素50gを加え、55℃で4時間放置した。その後冷却し酵母を加え、15日間発酵を行った。その後濾過器を用いて固液分離を行い、ろ液8Lを得た。これを85℃で30分加熱して本例品を得た。
・使用細胞:骨芽細胞(mouse Osteoblast MC3T3-E1)
・使用培地:DMEM
・使用試料:製造例11
6wellマイクロプレートに10%濃度で骨芽細胞を播種し、細胞が接着するまで37℃、5%CO2下前培養をおこなった。翌日細胞が接着している事を確認し、培地に対して所定濃度(5%)となるように試料を添加した。そして、37℃、5%CO2存在下で培養を行った。数日以内にコンフレントになることを確認し、27日後の細胞の様子を目視で評価を行った。なお、比較のため、水のみを添加した場合と、本発明者が既に出願した米エキス(特許文献1参照)を添加した場合も同様に試験した。その結果を図1に示す。ここで、図1(a)は水のみを添加した場合の写真、図1(b)は製造例11を添加した場合の写真、図1(c)は米エキスを添加した場合の写真である。図より明らかなように、製造例11を添加した場合には、水と比較して細胞の状態が顕著に良好であることが判明した。加えて、製造例11を添加した場合は、米エキスを添加した場合と比較して遜色ないことも判明した。尚、結果は明記しないが他の製造例についても同様の結果を得た。
Claims (5)
- 米を除く穀類又は豆類を必須的に含む原料の処理物を有効成分とすることを特徴とする寿命延長剤。
- 前記処理物が、前記原料の水抽出物又は有機溶媒抽出物である、請求項1記載の寿命延長剤。
- 前記処理物が、前記原料又は前記原料の水抽出物若しくは有機溶媒抽出物の糖化物である、請求項1記載の寿命延長剤。
- 前記処理物が、前記原料、前記原料の水抽出物又は有機溶媒抽出物、或いは、前記原料又は前記原料の水抽出物若しくは有機溶媒抽出物の糖化物の、アルコール発酵物又は有機酸発酵物である、請求項1記載の寿命延長剤。
- 米を除く穀類又は豆類が、小麦、大麦、トウモロコシ又は大豆である、請求項1〜4のいずれか一項記載の寿命延長剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005196003A JP5514390B2 (ja) | 2005-07-05 | 2005-07-05 | 米を除く穀類及び豆類を原料とする寿命延長剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005196003A JP5514390B2 (ja) | 2005-07-05 | 2005-07-05 | 米を除く穀類及び豆類を原料とする寿命延長剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007015941A true JP2007015941A (ja) | 2007-01-25 |
JP5514390B2 JP5514390B2 (ja) | 2014-06-04 |
Family
ID=37753417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005196003A Active JP5514390B2 (ja) | 2005-07-05 | 2005-07-05 | 米を除く穀類及び豆類を原料とする寿命延長剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5514390B2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009041515A1 (ja) * | 2007-09-27 | 2009-04-02 | Sapporo Breweries Limited | 骨吸収抑制剤、並びにこれを含有する飲料、食品及び医薬品 |
JP2011057642A (ja) * | 2009-09-14 | 2011-03-24 | National Agriculture & Food Research Organization | 神経突起伸展促進剤 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05310589A (ja) * | 1992-05-15 | 1993-11-22 | Soken Kk | 穀類からの活性酸素消去剤 |
JPH05310590A (ja) * | 1992-05-15 | 1993-11-22 | Soken Kk | 活性酸素消去剤 |
JPH05320061A (ja) * | 1992-05-19 | 1993-12-03 | Soken Kk | 豆類からの活性酸素消去剤 |
-
2005
- 2005-07-05 JP JP2005196003A patent/JP5514390B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05310589A (ja) * | 1992-05-15 | 1993-11-22 | Soken Kk | 穀類からの活性酸素消去剤 |
JPH05310590A (ja) * | 1992-05-15 | 1993-11-22 | Soken Kk | 活性酸素消去剤 |
JPH05320061A (ja) * | 1992-05-19 | 1993-12-03 | Soken Kk | 豆類からの活性酸素消去剤 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009041515A1 (ja) * | 2007-09-27 | 2009-04-02 | Sapporo Breweries Limited | 骨吸収抑制剤、並びにこれを含有する飲料、食品及び医薬品 |
JP5307019B2 (ja) * | 2007-09-27 | 2013-10-02 | サッポロビール株式会社 | 骨吸収抑制剤、並びにこれを含有する飲料、食品及び医薬品 |
JP2011057642A (ja) * | 2009-09-14 | 2011-03-24 | National Agriculture & Food Research Organization | 神経突起伸展促進剤 |
Also Published As
Publication number | Publication date |
---|---|
JP5514390B2 (ja) | 2014-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106794202B (zh) | 改善人类皮肤健康的组合物及其在制备产品中的用途 | |
CN101048166A (zh) | 除去异常蛋白质用组合物 | |
TWI516280B (zh) | 紅藜萃取物用於製備促進膠原蛋白生成及抗皮膚老化之組合物之用途 | |
CN105054076B (zh) | 一种有助于改善阿尔兹海默症的营养组合物及其应用 | |
JPH05139984A (ja) | 米からの活性酸素消去剤 | |
KR101025286B1 (ko) | 다시마의 발효에 의한 다량의 gaba를 함유한 발효산물 및 이를 이용한 기능성 천연 발효조미료와 다시마 발효분말의 제조 방법 | |
CN1735420A (zh) | 印度草药软饮料 | |
EP2330926A2 (en) | Therapeutic and nutritional food product and soup | |
JP5514390B2 (ja) | 米を除く穀類及び豆類を原料とする寿命延長剤 | |
CN102125196A (zh) | 蜂产品配方 | |
JP2009143886A (ja) | 成長ホルモン分泌促進剤 | |
JP6133471B2 (ja) | キサンチンオキシダーゼ阻害剤 | |
KR20090124815A (ko) | 화장료 조성물 및 그 제조방법 | |
CN110075280A (zh) | 一种层粘连蛋白肽复合口服剂及其制备方法 | |
JP5307969B2 (ja) | 白米由来成分を有効成分とする寿命延長剤 | |
CN105331477A (zh) | 一种白葡萄酒及其制备方法 | |
CN106176510A (zh) | 一种用于美容保健的口服物及相应的美容保健组合物 | |
JPH1075750A (ja) | にんにく系健康飲料 | |
JP2021529183A (ja) | 酵母抽出物を含む糖尿改善または抗酸化用の組成物と酵母抽出物の製造方法 | |
JP5296957B2 (ja) | 経口用老化防止剤 | |
CN110547449A (zh) | 一种富含γ-氨基丁酸的新型酵素口服片的制备方法 | |
CN104013853B (zh) | 一种健肾补肾的组合物及其制备方法 | |
JP6158147B2 (ja) | 美白剤及びこれを含有する内用又は外用組成物 | |
TWI795908B (zh) | 鹿茸萃取副產物水解物之製備方法及其用於治療或預防骨損傷相關疾病之用途 | |
JP5668018B2 (ja) | アルコール摂取障害予防剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080617 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110920 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111117 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111213 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120313 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120411 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20120601 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140331 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5514390 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |